IV PCA=intravenous patient-controlled analgesia; ORADE=opioid-related adverse drug event. Pooled rates of ORADEs from the four fentanyl ITS active-comparator trials (1) (2) (3) (4) • Utilizing the Premier costs and pooled ORADE rates from the fentanyl ITS clinical studies (1) (2) (3) (4) , the estimated weighted average per patient cost of ORADE event was $1,381 for fentanyl ITS and $1,783 for morphine IV PCA 
ORADE, Event Rate
See Table 1 Pooled analysis of the four active comparator trials for fentanyl ITS vs. IV PCA morphine (1) (2) (3) (4) This analysis pooled AE data for orthopedic subjects (1) (2) (3) (4) . Event rates were calculated for a pre-specified list of ORADE events. Of a total 1288 fentanyl ITS subjects and 1313 morphine IV PCA subjects, orthopedic subjects made up 45.8% and 47.7% of the treatment arms, respectively. For the analysis of IV PCA costs, each charge item from Premier used for this analysis is shown in Table 3 .
Medication Errors, Event Rate
• The total costs for categories that were made up of more than one charge code were calculated by taking the weighted average cost of all codes, adjusting the subtotal to 2014 USD and rounding the value to the nearest whole number. 
Background Methods
• A cost calculation model was developed to evaluate the economic value of fentanyl ITS compared to IV PCA morphine for a hospital performing inpatient orthopedic surgery.
• Duration of time modeled was 48 hours.
• The model considered: -Safety Outcomes: specifically, opioid-related adverse events (ORADEs) and IV PCA medication/device errors -Staff Utilization: hospital staff time -Consumables: supplies and equipment
• Model assumptions were informed by published literature, the Premier research database, fentanyl ITS active-controlled trial data (1-4), and online sources.
• Intravenous (IV) patient-controlled analgesia (PCA) is the most commonly used PCA and has become the standard practice for postoperative pain management in many setting.
• Fentanyl iontophoretic transdermal system (ITS) offers a new non-invasive PCA approach for the management of moderateto-severe acute postoperative pain.
-Fentanyl ITS is a novel self-contained, needle-free PCA adhesive system that actively delivers fentanyl transdermally.
-The efficacy and safety of fentanyl ITS in postoperative pain management as been assessed in 3 placebo-controlled trials and 4 active-controlled randomized controlled trials (RCTs).
Objective
• When selecting postoperative pain management (POPM) for an individual patient, clinicians weigh the analgesic efficacy, risk of adverse events, and any additional resource consumption associated with the administration of treatment.
• This analysis estimated the cost and resources associated with utilizing fentanyl iontophoretic transdermal system (ITS) versus standard IV PCA morphine for POPM, absent the cost of fentanyl ITS. 
